Zoetis, Inc. is the producer of medicine and vaccinations for pets and livestock. The Company has a diversified business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals); and within five major product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Company Growth (employees)
Type
Public
HQ
Parsippany Troy Hills, US
Founded
1952
Size (employees)
9,000 (est)
Website
zoetis.com
Zoetis was founded in 1952 and is headquartered in Parsippany-Troy Hills, US

Zoetis Office Locations

Zoetis has an office in Parsippany-Troy Hills
Parsippany-Troy Hills, US (HQ)
10 Sylvan Way

Zoetis Data and Metrics

Zoetis Financial Metrics

Zoetis's revenue was reported to be $1.2 b in Q1, 2018
USD

Revenue (Q1, 2018)

1.2 b

Gross profit (Q1, 2018)

788 m

Gross profit margin (Q1, 2018), %

64%

Market capitalization (19-Sep-2017)

32 b

Cash (02-Apr-2017)

629 m
Zoetis's current market capitalization is $32 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

4.6 b4.8 b4.8 b4.9 b

Revenue growth, %

5%(0%)3%

Cost of goods sold

1.7 b1.7 b1.7 b

Gross profit

2.9 b3.1 b3.2 b
USDQ2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b

Cost of goods sold

427 m421 m389 m399 m410 m443 m

Gross profit

748 m793 m773 m809 m831 m788 m

Gross profit Margin, %

64%65%67%67%67%64%
USDFY, 2016

Cash

727 m

Accounts Receivable

34.6 m

Inventories

1.5 b

Current Assets

3.4 b
USDQ2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

544 m592 m675 m658 m651 m629 m

Inventories

1.4 b1.4 b1.5 b1.5 b1.6 b1.5 b

Current Assets

3.3 b3.5 b3.3 b3.3 b3.4 b3.4 b

Goodwill

1.2 b1.2 b1.5 b1.5 b1.5 b1.5 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

819 m

Depreciation and Amortization

60 m60 m85 m

Accounts Receivable

15 m

Inventories

(101 m)
USDQ2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Depreciation and Amortization

15 m15 m21 m22 m21 m22 m

Inventories

1.4 b1.4 b1.5 b1.5 b1.6 b1.5 b

Accounts Payable

278 m306 m210 m224 m241 m231 m
Y, 2017

Financial Leverage

4.7 x
Show all financial metrics

Zoetis Market Value History

Zoetis Median Salaries

Source: 54 public H-1B filings from Zoetis

Traffic Overview of Zoetis

Zoetis Online and Social Media Presence

Zoetis News and Updates

Valeant Is Said to Be Hiring This Zoetis Exec as Its New CFO

He served as senior vice president of finance operations at Zoetis.

Valeant has reportedly poached a new CFO from the animal-health company Zoetis

The embattled drugmaker Valeant Pharmaceuticals is reportedly hiring a new chief financial officer from an animal-health company. Valeant is expected to announce its hire of Paul Herendeen, who on Friday resigned as CFO of Zoetis, on Monday, The Wall Street Journal's Vipal M…

Zoetis Company Life and Culture

You may also be interested in